These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6209081

  • 1. [Middle-molecular hydroxyethyl starch as a volume substitute. Its rheological effect in peripheral arterial occlusive diseases].
    Kiesewetter H, Blume J, Bulling B, Gerhards M, Jung F, Radtke H, Franke RP.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1844-7. PubMed ID: 6209081
    [Abstract] [Full Text] [Related]

  • 2. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Spitzer S, Bach R, Birk A, Schieffer H, Wenzel E.
    Schweiz Med Wochenschr; 1989 Dec 23; 119(51):1862-7. PubMed ID: 2481883
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
    Müller-Bühl U, Comberg HU, Diehm C, Allenberg J, Mörl H.
    MMW Munch Med Wochenschr; 1982 Mar 12; 124(10):241-3. PubMed ID: 6178019
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H, Jung F, Blume J, Spitzer S, Birk A.
    Acta Med Austriaca; 1991 Mar 12; 18 Suppl 1():23-7. PubMed ID: 1719729
    [Abstract] [Full Text] [Related]

  • 7. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J, Latza R, Pruss A, Kiesewetter H, Jung F, Meier C, Schimetta W.
    Clin Hemorheol Microcirc; 2000 Mar 12; 22(1):53-65. PubMed ID: 10711822
    [Abstract] [Full Text] [Related]

  • 8. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P, Langsteger W, Lind P, Klima G, Pierer G, Reisecker F, Eber O.
    Acta Med Austriaca; 1991 Mar 12; 18 Suppl 1():45-7. PubMed ID: 1719731
    [Abstract] [Full Text] [Related]

  • 9. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F, Waldhausen P, Mrowietz C, Spitzer S, Kiesewetter H, Wenzel E.
    Infusionstherapie; 1989 Aug 12; 16(4):148-54. PubMed ID: 2478482
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U, Hütt M, Herrmann B, Seufzer U, Leweling H.
    Infusionstherapie; 1989 Jun 12; 16(3):107-12. PubMed ID: 2474508
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients.
    Meyer P, Pernet P, Hejblum G, Baudel JL, Maury E, Offenstadt G, Guidet B.
    Acta Anaesthesiol Scand; 2008 Feb 12; 52(2):229-35. PubMed ID: 18034867
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Improvement of the flow properties of the blood of patients by low-molecular hydroxyethyl starch (Expafusin)].
    Landgraf H, Ruppel C, Saeger-Lorenz K, Vogel C, Ehrly AM.
    Infusionsther Klin Ernahr; 1982 Aug 12; 9(4):202-6. PubMed ID: 6182099
    [Abstract] [Full Text] [Related]

  • 18. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
    Treib J, Haass A, Pindur G, Grauer MT, Jung F, Wenzel E, Schimrigk K.
    Arzneimittelforschung; 1997 Jan 12; 47(1):18-22. PubMed ID: 9037438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M, Brechtelsbauer H, Akbulut C, Fett W, Briegel J, Finsterer U.
    Infusionsther Transfusionsmed; 1995 Apr 12; 22(2):74-80. PubMed ID: 7540445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.